This fourth article in a six-part series examines the potential use of hardwood tree species as components of engineered wood ...

Largest FDA-authorized Phase 2 cell therapy trial conducted in chronic lumbar disc diseaseThe study has enrolled a total of 99 participants, each ...

The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that been granted expedited review through ...

By Sneha S K Feb 13 (Reuters) - Disc Medicine said on Friday the U.S. Food and Drug Administration declined to approve its ...

Sarah Jividen, RN, BSN, is a trained neuro/trauma, and emergency room nurse turned healthcare writer. As a journalism major, she combined her love for writing with her passion for high-level patient ...

Gregory Poulter, MD, a spine surgeon at Indianapolis-based OrthoIndy, has debuted Surgical Theater’s newly cleared SyncAR Spine platform.  The FDA recently granted 510(k) clearance to the platform, ...

Dymicron, the company developing the Triadyme-C cervical disc, added Peter Wehrly to its board of directors, according to a Feb. 19 news release. Mr. Wehrly has extensive experience in the medtech ...

Spanberger takes further steps to remove Virginia from ICE operations ICE suffers triple legal blow within hours CBS News pulls '60 Minutes' segment with Peter Attia from rerun after Epstein files ...

A clinical trial at Brown University Health to treat chronic low back pain with a one-time, non-surgical injection treatment is seeking to enroll patients in Rhode Island. The trial is testing whether ...

Global contract manufacturer offering in‑house extrusions, balloons, and EM sensors. Builds 7M+ devices annually, including ...